Menu

• Ask a Health Expert about MANTLE CELL LYMPHOMA
• Post Your Side Effect related to MANTLE CELL LYMPHOMA
• MANTLE CELL LYMPHOMA and FDA Warnings
• MANTLE CELL LYMPHOMA in Patients Wiki
• Report MANTLE CELL LYMPHOMA in Drug Side Effect Survey

MANTLE CELL LYMPHOMA side effect

What is MANTLE CELL LYMPHOMA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Fluorouracil Side Effects Report #5788954-2
Physician from SWEDEN reported FLUOROURACIL problem on June 19, 2008. Female patient, weighting 130.1 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: mantle cell lymphoma, neoplasm malignant, . FLUOROURACIL dosage: unknown. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE. Patient died on 03/11/2006.

Methotrexate Side Effects Report #5724691-8
METHOTREXATE problem was reported by a Consumer or non-health professional from AUSTRALIA on Apr 23, 2008. Male patient, 75 years of age, was diagnosed with myasthenia gravis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: mantle cell lymphoma, . METHOTREXATE dosage: unknown. Patient recovered.

Remicade Side Effects Report #5622858-0
Physician from UNITED STATES reported REMICADE problem on Feb 04, 2008. Male patient, weighting 158.0 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: infection, mantle cell lymphoma, nail discolouration, onychomadesis, rash, . REMICADE dosage: unknown. During the same period patient was treated with ENBREL, HUMIRA. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5642201-0
ZEVALIN problem was reported by a Physician from UNITED STATES on Feb 14, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, mantle cell lymphoma, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXAN. Patient was hospitalized. Patient recovered.


Remicade Side Effects Report #5597396-4
Physician from UNITED STATES reported REMICADE problem on Jan 10, 2008. Male patient, weighting 158.0 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: infection, mantle cell lymphoma, nail discolouration, onychomadesis, rash, . REMICADE dosage: unknown. During the same period patient was treated with ENBREL, HUMIRA. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5570317-6
REMICADE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2007. Male patient, 58 years of age, weighting 158.0 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: impaired work ability, mantle cell lymphoma, non-hodgkin's lymphoma, stem cell transplant, . REMICADE dosage: unknown. During the same period patient was treated with HUMIRA, ENBREL. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5474428-5
Physician from UNITED STATES reported REMICADE problem on Sept 21, 2007. Male patient, weighting 158.0 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: infection, mantle cell lymphoma, nail discolouration, onychomadesis, rash, . REMICADE dosage: unknown. During the same period patient was treated with ENBREL, HUMIRA. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5452255-2
REMICADE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Male patient, 58 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: infection, mantle cell lymphoma, nail discolouration, onychomadesis, rash, . REMICADE dosage: unknown. During the same period patient was treated with ENBREL, HUMIRA. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5455219-8
Consumer or non-health professional from UNITED STATES reported REMICADE problem on Sept 11, 2007. Male patient, 58 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: infection, mantle cell lymphoma, nail discolouration, onychomadesis, rash, . REMICADE dosage: unknown. During the same period patient was treated with ENBREL, HUMIRA. Patient was hospitalized. Patient recovered.


Revlimid Side Effects Report #5761970-2
REVLIMID problem was reported by a Physician from UNITED STATES on May 28, 2008. Male patient, 85 years of age, was diagnosed with mantle cell lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, mantle cell lymphoma, . REVLIMID dosage: 25 MG, DAILY 21 DAYS Q 28 DAYS, ORAL. Patient died on 04/07/2008.

Methotrexate Side Effects Report #5648881-8
Health Professional from AUSTRALIA reported METHOTREXATE problem on Feb 25, 2008. Male patient, 75 years of age, was diagnosed with myasthenia gravis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, lymphocyte count increased, mantle cell lymphoma, platelet count decreased, white blood cell count increased, . METHOTREXATE dosage: 17.5 MG WEEKLY. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, PREDNISOLONE, PYRIDOSTIGMINE BROMIDE. Patient recovered.

Temsirolimus Side Effects Report #5743594-6
TEMSIROLIMUS problem was reported by a Physician from UNITED STATES on May 16, 2008. Male patient, weighting 135.1 lb, was diagnosed with mantle cell lymphoma, arrhythmia, diarrhoea, neuropathy peripheral, hypertension, pain and was treated with TEMSIROLIMUS. After drug was administered, patient experienced the following problems/side effects: duodenal perforation, malignant neoplasm progression, mantle cell lymphoma, pleural effusion, . TEMSIROLIMUS dosage: 175 MG WK 1+2; HELD WK 3; 75 MG WK 4 +5; HELD WK 6. During the same period patient was treated with DIGOXIN, IMODIUM, NEURONTIN, LOMOTIL, CARVEDILOL, VICODIN. Patient was hospitalized. Patient died on 04/20/2006.